While wild-type TDP-43 is the key pathogenic substrate in the majority of these ALS and FTLD patients, mutant forms of TDP-43 can also drive ALS pathology in those carrying a TARDBP missense mutation. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.